Nutrabolics Supernova
Natural health product licensed in Canada
- Licence holder
- Nutrabolics Inc.
- NPN or DIN-HM
- 80068842
- Status
- Active licence
- Licence date
- 25 April 2016
- Revision date
- 4 March 2021
- Form
- Poudre pour solution
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide 3-aminopropanoïque Source : Beta-alanine | 1,500 milligramme | Not calculated |
| Theobroma cacao Source : Graine(s) Potency : 12 % Theobromine | Not specified | Not calculated |
| Dendrobium nobile Source : Tige | 600 milligramme | Not calculated |
| L-théanine | 100 milligramme | Not calculated |
| Sel interne d'hydroxyde de (carboxyméthyl)triméthylammonium Source : Bétaïne | 1,500 milligramme | Not calculated |
| 1,3,7-triméthylxanthine Source : Caféine | 200 milligramme | Not calculated |
| Citrus aurantium Source : Pelure (fruit) Extraction ratio : 5:1 Dry plant equivalent : 500 milligramme Potency : 30 % Synephrine | 100 milligramme | Not calculated |
| [5R-(5alpha, 9beta, 11E)]-5-amino-11-éthylidène-5 ,6,9,10-tétrahydro-7-méthyl-5 ,9-méthane-cycloocta [b] pyridine-2 (1H)-one Source : Huperzia serrata - plante entière | 150 microgrammes | Not calculated |
| Malate de citrulline Source : Malate de citrulline Potency : 50 % Citrulline | 6,000 milligramme | Not calculated |
| Theobroma cacao Source : Graine(s) Extraction ratio : 4:1 Dry plant equivalent : 1,200 milligramme Potency : 9 % Caffeine | 300 milligramme | Not calculated |
Non-medicinal ingredients
Acésulfame potassium, Bêta-carotène, Saveur, Acide l-tartrique, Sucralose, Betterave rouge, Rocou, Acide citrique, Acide L-malique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Portion(s) | 1 Tous les jours |
Uses authorised in Canada
Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Supports an increase in athletic performance in high-intensity anaerobic exercise with short rest periods.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or breastfeeding. Not recommended for children. Adult use only. Do not use if you have cardiovascular disease risk factors (eg: high blood pressure, high cholesterol and/or triglycerides) or glaucoma). Do not consume if you are taking congestant-containing cold preparations (eg: phenylephrine or pseudoephedrine), products containing ephedra or ephedrine, or other medications which increase blood pressure.
- Effets indésirables connus
May cause stomach discomfort. Discontinue use if stomach discomfort occurs. Hypersensitivity/allergy is known to occur, in which case, discontinue use. May cause a flushing, tingling and/or prickling sensation of the skin, in which case, reduce the dose. Caffeine has been shown to reduce blood flow to the heart muscle during exercise which might lead to cardiovascular complications such as chest pain, and irregular heartbeat even in healthy individuals. If those symptoms occur discontinue use and consult a health care practitioner. Anxiety, tachycardia (rapid heart rate), palpitations, insomnia, restlessness, dizziness, drowsiness, fatigue, edema nausea, nervousness, tremor and headache may occur; in which case discontinue use and consult a health care practitioner.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking lithium. Consumption with other caffeine-containing products is not recommended as it may increase the risk of adverse effects. This product is not intended as a substitute for sleep. Consult a health care practitioner prior to use if you have detrusor instability (overactive bladder syndrome). Consult a health care practitioner prior to use if you have diabetes, prostate disorders or are taking prescription medication.
Source
Official Health Canada record, licence 80068842
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging